BSEM

BioBlue Technologies, Inc. develops and provides tissue-based solutions primarily for surgical and wound care applications. The company specializes in perinatal tissue allografts, utilizing proprietary processing methods to maintain the natural structural and molecular integrity of the tissues. Its product offerings include advanced wound care and surgical care products, supported by extensive research and clinical applications. BioBlue serves healthcare providers and clinicians, focusing on enhancing patient outcomes in various surgical settings.